Masimo Acquired by Danaher | Healthcare M&A Deal

Danaher has acquired Masimo, a diagnostics imaging business in Washington, for $9.9 billion. Danaher acquires Masimo to expand pulse oximetry and patient monitoring capabilities in acute care settings, strengthening its diagnostics imaging platform. Masimo’s sensor technology and AI-enabled monitoring are expected to enhance clinical decision-making and accelerate Danaher acquisitions within healthcare M&A. This strategic acquisition is a platform acquisition by a strategic buyer, valued at about $180 per share in cash, with expected close in the second half of 2026 subject to regulatory clearances and Masimo shareholder approval. Danaher acquisitions are also expected to be accretive to adjusted diluted net earnings per share and generate more than $530 million of EBITDA in 2027, supported by over $125 million of annual cost synergies and over $50 million of annual revenue synergies.